Skip to main content
Sign In

Marsha S. Anderson, MD

Associate Professor of Pediatrics


Associate Program Director, Pediatric Residency Program

   Phone: 720-777-1234 (TBD)
   E-mail: (TBD)

Section of Infectious Diseases, Department of Pediatrics
Pediatric Medical Education
Children's Hospital Colorado

Pediatrics, Pediatric Infectious Diseases

Marsha S. Anderson, MD, earned her physician assistant certification from the University of Iowa in 1982 and graduated from the University of Tennessee School of Medicine in 1991. At the University of Colorado School of Medicine, Dr. Anderson completed pediatric residency training in 1994, served as Chief Resident from 1994 to 1995, and in 1998 completed her pediatric infectious diseases fellowship training. In 1998 she joined the faculty of the Department of Pediatrics and Children's Hospital Colorado. She has participated in numerous committees and task forces, including the Program Committee for Pediatric Resident Education and the Bioterrorism Task Force. She served as Director of Inpatient Medicine at Children's Hospital Colorado from 1998 to 2005 and was appointed Associate Program Director of the Pediatric Residency Program in 2005.

Dr. Anderson's academic interests involve outcomes-related research, including the development of a tool to assess inpatient outcomes and adverse events, as well as research regarding medical errors, Kawasaki disease, and bioterrorism. She performs clinical research on vaccines, vaccine-preventable disease, and Kawasaki disease.

Dr. Anderson has published numerous journal articles, book chapters, and abstracts. She is a popular speaker and lecturer.

  • America’s Top Pediatricians, 2004-present
  • Assistant Dean, Longitudinal Curriculum, CU School of Medicine, 2011
  • Vaccine Advocacy Taskforce, Pediatric Infectious Disease Society, 2010
  • Member, Academy of Medical Educators, CU School of Medicine, 2010
  • Dominguez SR, Briese T, Palacios G, Hui J, Villari J, Kapoor V, Tokarz R, Glodé MP, Anderson MS, Robinson CC, Holmes KV, Lipkin WI. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol. 2008 Oct;43(2):219-22. [PMID: 18674964]
  • Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Kawasaki disease in a pediatric intensive care unit: a case control study. 2008;122(4):e786-90. [PMID: 18809597]
  • Deterding RR, Wong S, Faries G, Glover JJ, Garrington TP, Wang M, Anderson MS, Krugman RD. The new University of Colorado medical school curriculum: a pediatric perspective. J Pediatr. 2007 Nov;151(5 Suppl):S32-6. [PMID: 17950321]
  • Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS. A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1. Clin Immunol. 2007 Nov;125(2):131-7. [PMID: 17825626]
  • Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, Oberste MS, Glodé MP. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007 Oct;45(8):950-7. [PMID: 17879907]
  • Dominguez SR, Anderson MS, Glodé MP, Robinson CC, Holmes KV. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis. 2006 Dec;194(12):1697-701. [PMID: 17109341]
  • Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics. 2005 Apr;115(4):e428-33. [PMID: 15805345]
  • Ogle JW, Anderson MS. Infections: bacterial and spirochetal. In: Hay WW Jr., Levin MJ, Sondheimer JM, Deterding RR, editors. Current pediatric diagnosis and treatment. 17th ed. New York: McGraw-Hill; 2005.